To provide the information your oncologist is not telling you or doesn't have the time to!
EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) EGFR (epidermal growth factor receptor) is a protein located on the surface of cells that regulates their growth and division. Mutations in the EGFR gene can lead to uncontrolled cell growth and are commonly found in various cancers, including non-small cell lung cancer (NSCLC). In patients with unresectable stage …
In the ever-evolving landscape of cancer care, the role of the oncology nurse navigator has emerged as a cornerstone of patient support and care coordination. In this post, we’ll explore the origins of oncology navigation, emerging trends, and what the future holds. We will also include some significant changes in billing practices that are on …
Stage III melanoma means the cancer has spread beyond the original tumor to nearby areas but hasn’t reached distant parts of the body. The prognosis for Stage III melanoma varies depending on several factors, including the extent of lymph node involvement, the presence of in-transit or satellite lesions, and the patient’s overall health. Treatment for …
Maintaining good health is vital for everyone, but it’s especially crucial for patients diagnosed with cancer. This becomes even more important to those participating in clinical trials, where the physical and mental demands can be significant. Ensuring balanced diet and regular exercise can play a key role in supporting your overall well-being throughout this challenging …
In the realm of oncology, the journey from diagnosis to treatment is often marked by a maze of medical, emotional, and logistical challenges. Oncology nurse navigators are specialized nurses who serve as a bridge between patients, their families, and the healthcare system. Our primary goal is to ensure that patients receive comprehensive, coordinated care while …
As I step away from my role as a medical oncologist at Orlando Health, I find myself reflecting on the remarkable journey that has spanned the last 13 years. It’s a bittersweet moment, filled with a mix of gratitude, pride, and anticipation for what lies ahead as I finish up my last days by the …
Multiple myeloma (MM) is a type of blood cancer that originates in the plasma cells, which are a type of white blood cell found in the bone marrow. Plasma cells are responsible for producing antibodies that help fight infections. In multiple myeloma, abnormal plasma cells multiply uncontrollably, leading to a range of complications. Key Characteristics …
When it comes to battling a rare and aggressive cancer like synovial sarcoma, the treatment options have often been limited—until now. The FDA’s recent approval of Tecelra (Amafi-Cel), the first gene therapy for adults with metastatic synovial sarcoma, not only provides new hope for patients who’ve exhausted other options but also paves the way for …
Deciding to join a clinical trial can feel daunting, especially with the myths and misconceptions that surround them. Let’s take a moment to clear the air and set the record straight about what clinical trials really mean for you as a patient. Myth #1: “I’m Just a Lab Rat” Contrary to popular belief, participating in …
Meet Sarah, a resilient woman in her late 40s who has been battling stage IV metastatic melanoma. After enduring the uncertainties of her diagnosis, Sarah achieved a remarkable remission through immunotherapy, a victory that brought her and her loved ones immense relief. However, the journey doesn’t end there. Sarah now faces the ongoing challenge of …